References
- Prepared by the Committee for Evaluating Medical Technologies in Clinical Use. Assessing Medical Technologies. Eddy DM (Ed.). National Academy Press, Washington DC, USA (1985).
- Halpern MT, Luce BR, Brown RE, Genste B. Health and economic outcomes modeling practices: a suggested framework. Value Health1(2), 131–147 (1998).
- •Good review of modeling practices before, during and after model development.
- Hay J, Jackson JC, Luce B, Avom J, Ashraf T Panel 2: methodological issues in conducting pharmacoeconomic evlauations — modeling studies. Value Health 2(2), 78–81 (1999).
- Weinstein MC, O'Brien B, Homberger J et al Principles of good practice for decision analytic modeling in healthcare evaluation: report of the ISPOR Task Force on Good Research Practices — Modeling Studies. Value Health 6 (1), 9–17 (2003) .
- ••Recent article summarizing some of theimportant principles of good modeling practice.
- Akehurst R, Anderson P, Brazier J et al Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. PharmacoEconomics 17(5), 443–444 (2000).
- •Good overview of properties of good decision analytic models.
- Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effective models. A suggested framework and example of application. PharmacoEconomics 17(5), 461–477 (2000).
- ••Detailed attempt towards developing aframework for assessing quality in decision analytic models.
- Sonnenberg FA, Roberts MS, Tsevat J, Wong JB, Barry M, Kent DL. Toward a peer review process for medical decision analysis models. Med. Cate 32\(Suppl. 7), S52—S64 (1994).
- Brennan A, Akehurst R. Modelling in health economic evaluation. What is its place? What is its value? PharmacoEconomics 17(5), 445–459 (2000).
- McCabe C, Dixon S. Testing the validity of cost-effectiveness models. PharmacoEconomics 17(5), 501–513 (2000).
- •Good review of the various components of testing validity in models.
- Glick H, Kinosian B, Schulman K. Decision analytic modeling: some uses in the evaluation of new pharmaceuticals. Drug Information 28, 691–707 (1994).
- Goeree R, O'Brien B. Cost-effectiveness modeling in rheumatology: toward principles of good practice. I Rheumatology 30\(Suppl. 68), 21 (2003).
- •Brief summary of modeling principles around model structure, data inputs and model validation.
- Sheldon T Problems of using modelling in the economic evaluation of healthcare. Health Economics5, 1–11 (1996).
- Sendi PP, Craig BA, Pfluger D, Gafni A, Bucher HC for the Swiss HIV Cohort Study. Systematic validation of disease models for pharmacoeconomic evaluations. Eva. Clin. Prac. 5(3), 283–295 (1999).
- Anderson M, Woessner W. The role of the post-audit in model validation. Adv Water Resowres 15,167–173 (1992).